(Wall Street Journal) – China approved its first homegrown mRNA vaccine for Covid-19, adding a key tool to combat future outbreaks of the virus that was missing due to Beijing’s reluctance to allow Western-made shots using the gene-based technology. CSPC Pharmaceutical Group Ltd.’s messenger-RNA vaccine, known as SYS6006, was given emergency-use clearance by regulators, the

This content was originally published here.